Coughing Biden says he has a cold
- Wall St sinks as yields spike, financials fall after Goldman miss
- Largest Tech Deal Ever: Microsoft (MSFT) Buys Activision Blizzard (ATVI) for $68.7 Billion, Seen as an 'Aggressive Consumer Acquisition'
- Tesla (TSLA) Price Target Raised at Credit Suisse, Analyst Names 4 Catalysts for 2022
- Goldman Sachs (GS) Misses Q4 EPS by 95c, Revenue Beats
- 'Buy Now': Boeing (BA) Stock Gains as Bernstein Names it Top Choice for 2022, Sees Several Near-Term Catalysts
U.S. President Joe Biden coughs as he delivers remarks on the November jobs report at the White House in Washington, U.S., December 3, 2021. REUTERS/Kevin Lamarque
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
WASHINGTON (Reuters) -A hoarse-sounding U.S. President Joe Biden said on Friday he has a cold, possibly contracted from a grandson.
After a speech about the U.S. economy in which he sounded congested and coughed several times, reporters asked Biden if he was okay.
"I'm OK," Biden said. "What I have is a one-and-a-half year old grandson who has a cold who likes to kiss his pop ... it's just a cold."
Biden has been tested three times for COVID-19 this week and the tests have turned up negative, according to his physician, Kevin O'Connor.
In a letter distributed to the press, the doctor said that Biden is experiencing "nasal congestion" and a "frog in ones throat."
He is being treated with over-the-counter medications.
(Reporting by Trevor Hunnicutt and Steve Holland, Editing by Louise Heavens)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. antitrust enforcers plan to toughen merger guidelines
- Teva settles shareholder lawsuit over generic drug pricing for $420 million
- Second Syria torture trial opens in Germany
Create E-mail Alert Related CategoriesPolitics, Reuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!